Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Observatoire Français de la Sclérose en Plaques (OFSEP): A unique multimodal nationwide MS registry in France.

Vukusic S, Casey R, Rollot F, Brochet B, Pelletier J, Laplaud DA, De Sèze J, Cotton F, Moreau T, Stankoff B, Fontaine B, Guillemin F, Debouverie M, Clanet M; the OFSEP Investigators.

Mult Scler. 2018 Dec 13:1352458518815602. doi: 10.1177/1352458518815602. [Epub ahead of print]

PMID:
30541380
2.

OFSEP, a nationwide cohort of people with multiple sclerosis: Consensus minimal MRI protocol.

Cotton F, Kremer S, Hannoun S, Vukusic S, Dousset V; Imaging Working Group of the Observatoire Français de la Sclérose en Plaques.

J Neuroradiol. 2015 Jun;42(3):133-40. doi: 10.1016/j.neurad.2014.12.001. Epub 2015 Feb 7. Review.

PMID:
25660217
3.

Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification Among Natalizumab Users in France.

Vukusic S, Rollot F, Casey R, Pique J, Marignier R, Mathey G, Edan G, Brassat D, Ruet A, De Sèze J, Maillart E, Zéphir H, Labauge P, Derache N, Lebrun-Frenay C, Moreau T, Wiertlewski S, Berger E, Moisset X, Rico-Lamy A, Stankoff B, Bensa C, Thouvenot E, Heinzlef O, Al-Khedr A, Bourre B, Vaillant M, Cabre P, Montcuquet A, Wahab A, Camdessanché JP, Tourbah A, Guennoc AM, Hankiewicz K, Patry I, Nifle C, Maubeuge N, Labeyrie C, Vermersch P, Laplaud DA; OFSEP Investigators.

JAMA Neurol. 2019 Sep 3. doi: 10.1001/jamaneurol.2019.2670. [Epub ahead of print]

PMID:
31479149
4.
5.

[Care pathway diversity of patients with multiple sclerosis between French regions].

Blein C, Chamoux C, Reynaud D, Lepage V.

Rev Epidemiol Sante Publique. 2018 Nov;66(6):385-394. doi: 10.1016/j.respe.2018.08.006. Epub 2018 Oct 8. French.

PMID:
30309672
6.

Is the Choosing Wisely® campaign model applicable to the management of multiple sclerosis in France? A GRESEP pilot study.

Trumbic B, Zéphir H, Ouallet JC, Le Page E, Laplaud D, Bensa C, de Sèze J.

Rev Neurol (Paris). 2018 Jan - Feb;174(1-2):28-35. doi: 10.1016/j.neurol.2017.06.016. Epub 2017 Nov 8.

PMID:
29128151
7.

[Cost of multiple sclerosis in France].

Fromont A, Lehanneur MN, Rollot F, Weill A, Clerc L, Bonithon Kopp C, Binquet C, Moreau T.

Rev Neurol (Paris). 2014 Jun-Jul;170(6-7):432-9. doi: 10.1016/j.neurol.2014.02.007. Epub 2014 May 22. French.

PMID:
24856285
8.

Targeted clinical audits immediately following the establishment of clinical practice guidelines for multiple sclerosis in 17 neurology departments: A pragmatic and collaborative study.

Lairy G, Zephir H, Ouallet JC, Le Page E, Laplaud D, Bensa C, De Seze J.

Rev Neurol (Paris). 2015 May;171(5):407-14. doi: 10.1016/j.neurol.2015.03.006. Epub 2015 Apr 23.

PMID:
25912471
9.

A comparative study on iMed(©) and European database for multiple sclerosis to propose a common language of multiple sclerosis data elements.

Ajami S, Ahmadi G, Saghaeiannejad-Isfahani S, Etemadifar M.

J Educ Health Promot. 2014 Nov 29;3:107. doi: 10.4103/2277-9531.145894. eCollection 2014.

10.

Multiple sclerosis and pregnancy.

Bodiguel E, Bensa C, Brassat D, Laplaud D, Le Page E, Ouallet JC, Zephir H, De Seze J; Groupe de Réflexion sur la Sclérose en Plaques.

Rev Neurol (Paris). 2014 Apr;170(4):247-65. doi: 10.1016/j.neurol.2013.09.010. Epub 2014 Mar 28.

PMID:
24684929
11.

Recommendations for the detection and therapeutic management of cognitive impairment in multiple sclerosis.

Bensa C, Bodiguel E, Brassat D, Laplaud D, Magy L, Ouallet JC, Zephir H, De Seze J, Blanc F; Multiple Sclerosis Think Tank (Groupe de reflexion sur la sclerose en plaques GRESEP).

Rev Neurol (Paris). 2012 Nov;168(11):785-94. doi: 10.1016/j.neurol.2012.02.009. Epub 2012 Jun 2.

PMID:
22658753
12.

Recommendations for the management of multiple sclerosis relapses.

Laplaud D, Bodiguel E, Bensa C, Blanc F, Brassat D, Magy L, Ouallet JC, Zephir H, De Seze J; GRESEP (Groupe de Reflexion sur la Sclerose en Plaques; Multiple Sclerosis Think Tank).

Rev Neurol (Paris). 2012 May;168(5):425-33. doi: 10.1016/j.neurol.2012.02.006. Epub 2012 May 1.

PMID:
22555010
13.

The incidence and prevalence of multiple sclerosis in Nova Scotia, Canada.

Marrie RA, Fisk JD, Stadnyk KJ, Yu BN, Tremlett H, Wolfson C, Warren S, Bhan V; CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis.

Can J Neurol Sci. 2013 Nov;40(6):824-31.

PMID:
24257224
14.

Multiple sclerosis registry in Germany: results of the extension phase 2005/2006.

Flachenecker P, Stuke K, Elias W, Freidel M, Haas J, Pitschnau-Michel D, Schimrigk S, Zettl UK, Rieckmann P.

Dtsch Arztebl Int. 2008 Feb;105(7):113-9. doi: 10.3238/arztebl.2008.0113. Epub 2008 Feb 15.

15.

The Swiss Multiple Sclerosis Registry (SMSR): study protocol of a participatory, nationwide registry to promote epidemiological and patient-centered MS research.

Steinemann N, Kuhle J, Calabrese P, Kesselring J, Disanto G, Merkler D, Pot C, Ajdacic-Gross V, Rodgers S, Puhan MA, von Wyl V; Swiss Multiple Sclerosis Registry.

BMC Neurol. 2018 Aug 13;18(1):111. doi: 10.1186/s12883-018-1118-0.

16.

[Difficulties experienced at work by patients with multiple sclerosis].

Ongagna JC, Passadori A, Pinelli J, Isner-Horobeti ME, Zaenker C, De Seze J.

Rev Neurol (Paris). 2015 Nov;171(11):782-6. doi: 10.1016/j.neurol.2015.06.007. Epub 2015 Sep 3. French.

PMID:
26343923
17.

[Pediatric multiple sclerosis: is it different from the adult form?].

Araqi-Houssaini A, Dany F, Sekkat Z, Camara NA, Hazim A, Midafi N, Elotmani H, El Moutawakil B, Rafai MA, Slassi I.

Rev Neurol (Paris). 2014 Aug-Sep;170(8-9):531-5. doi: 10.1016/j.neurol.2014.07.004. Epub 2014 Aug 28. French.

PMID:
25174885
19.

European validation of a standardized clinical description of multiple sclerosis.

Amato MP, Grimaud J, Achiti I, Bartolozzi ML, Adeleine P, Hartung HP, Kappos L, Thompson A, Trojano M, Vukusic S, Confavreux C; Evaluation of the EDMUS system (EVALUED) Study Group.

J Neurol. 2004 Dec;251(12):1472-80.

PMID:
15645346

Supplemental Content

Support Center